NF-κB is one of the most well-known molecular pathways involved in cancer and has been considered a prototypical pro-inflammatory signaling pathway, activated by cytokines such as interleukin 6 (IL-6) and TNF-α [81,82]. This evidence concerns the gene IL6 and cancer.